Organisms | Evidence |
---|---|
Human immunodeficiency virus 1 |
Gene Symbol | Donor | Acceptor | Reducing terminal(Acceptor) | Product | Reducing terminal(Product) | Reference |
---|---|---|---|---|---|---|
C1GALT1 | (not applicable) |
|
Ser/Thr |
|
Ser/Thr | |
ST6GALNAC1 | CMP-Neu5Ac |
|
Ser/Thr |
|
Ser/Thr | |
ST6GALNAC1 | CMP-Neu5Ac |
|
O-glycan Synthesis |
|
O-glycan Synthesis | |
B3GNT6 | UDP-GlcNAc |
|
[alpha]-pNP |
|
[alpha]-pNP |
Gene Symbol | Donor | Acceptor | Reducing terminal(Acceptor) | Product | Reducing terminal(Product) | Reference |
---|---|---|---|---|---|---|
C1GALT1 | (not applicable) |
|
Ser/Thr |
|
Ser/Thr | |
ST6GALNAC1 | CMP-Neu5Ac |
|
Ser/Thr |
|
Ser/Thr | |
ST6GALNAC4 | CMP-Neu5Ac |
|
benzyl |
|
benzyl | |
ST6GALNAC1 | CMP-Neu5Ac |
|
O-glycan Synthesis |
|
O-glycan Synthesis | |
ST6GALNAC1 | CMP-Neu5Ac |
|
[Ala-Thr(*)-Ala]2-7 |
|
[Ala-Thr(*)-Ala]2-7 |
Gene Symbol | Donor | Acceptor | Reducing terminal(Acceptor) | Reference |
---|---|---|---|---|
ST6GALNAC3 | CMP-Neu5Ac |
|
Ser/Thr | |
ST6GAL2 | CMP-Neu5Ac |
|
para-nitrophenol | |
ST6GALNAC2 | CMP-Neu5Ac |
|
benzyl | |
ST6GALNAC1 | CMP-Neu5Ac |
|
[alpha]-Bz | |
ST6GALNAC2 | CMP-Neu5Ac |
|
Ser/Thr |
UniProt ID | Protein Name | Reference | Source |
---|---|---|---|
P16422 | Epithelial cell adhesion molecule | ||
P16860 | Natriuretic peptides B | ||
P17813 | Endoglin | ||
P17936 | Insulin-like growth factor-binding protein 3 | ||
P18065 | Insulin-like growth factor-binding protein 2 | ||
P18075 | Bone morphogenetic protein 7 | ||
P18084 | Integrin beta-5 | ||
P18684 | Diptericin-D | ||
P18827 | Syndecan-1 | ||
P18850 | Cyclic AMP-dependent transcription factor ATF-6 alpha |
Pathway Name | Organism |
---|---|
E.coli O101 | Escherichia coli |
E.coli O103 | Escherichia coli |
E.coli O107 | Escherichia coli |
E.coli O112ab | Escherichia coli |
E.coli O112ac | Escherichia coli |
E.coli O116 | Escherichia coli |
E.coli O117 | Escherichia coli |
E.coli O125ab | Escherichia coli |
E.coli O127 | Escherichia coli |
E.coli O128ab-H27 | Escherichia coli |
RES 1b:a-dgal-HEX-1:5 2s:n-acetyl LIN 1:1d(2+1)2n
PubMed ID | Title | First Author | Publication Date | Source |
---|---|---|---|---|
7505088 | Sugar-binding sites with specificity to N-acetyl-d-glucosaminides in middle ear mucosa of the guinea pig | Tanimural F | 1993 Oct |
|
7503962 | alpha GalNAc is essential for recognition of Exo-1 epithelial antigen by mouse monoclonal antibody Pa-G-14 | Schröder H | 1993 Nov 11 |
|
7683697 | Persistent repression of a functional allele can be responsible for galactosyltransferase deficiency in Tn syndrome | Thurnher M | 1993 May |
|
8351977 | Analysis of lectin binding sites in the gut of hooded Lister rats with special emphasis on recently detected lectins | Schumacher U | 1993 May |
|
8372535 | GalNAc/Gal specific lectin from German iris (Iris germanica L.) rootstock. | Ferens-Sieczkowska M | 1993 Mar 31 |
|
8464073 | Crystallization and Preliminary Crystallographic Analysis of a Tetrameric Isolectin from Vicia villosa, Specific for the Tn Antigen | Eiselé JL | 1993 Mar 20 |
|
7681454 | Postnatal development and localization of an N‐acetylgalactosamine containing glycoconjugate associated with nonpyramidal neurons in cat visual cortex | Schweizer M | 1993 Mar 15 |
|
7681597 | Epitopic structure of Tn glycophorin A for an anti-Tn antibody (MLS 128) | Nakada H | 1993 Mar 15 |
|
8460945 | Structures of Mucin-Type Sugar Chains on Human Erythropoietins Purified from Urine and the Culture Medium of Recombinant Chinese Hamster Ovary Cells | Inoue N | 1993 Mar |
|
8501124 | Early lipid intermediates in glycosyl-phosphatidylinositol anchor assembly are synthesized in the ER and located in the cytoplasmic leaflet of the ER membrane bilayer. | Vidugiriene J | 1993 Jun 01 |
|
GlyCosmos is a member of the GlySpace Alliance together with GlyGen and Glycomics@ExPASy.
Supported by JST NBDC Grant Number JPMJND2204
Partly supported by NIH Common Fund Grant #1U01GM125267-01
This work is licensed under Creative Commons Attribution 4.0 International
GlyCosmos Portal v4.2.1
Last updated: April 7, 2025